Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - gatifloxacin -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - gatifloxacin -

Canada - English - Health Canada

abbvie corporation - gatifloxacin - solution - 0.3% - gatifloxacin 0.3% - antibacterials

Israel - English - Ministry of Health

allergan israel ltd - gatifloxacin 3 mg/ml - ophthalmic solution - gatifloxacin - zymar is indicated for the treatment of bacterial conjunctivitis caused by suspectible strains of the following organisms : aerobic gram - positive bacteria : cornyebacterium propinquum - staphylococcus aureus - staphylococcus epidermidis - streptococcus mitis - streptococcus pneumoniae. aerobic gram - negative bacteria : - haemophilus influenza. - efficacy for this organisms was studied in fewer than 10 infections.

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - gatifloxacin - solution - 3 mg/ml - gatifloxacin 3 mg/ml

United States - English - NLM (National Library of Medicine)

allergan, inc. - gatifloxacin (unii: l4618bd7kj) (gatifloxacin anhydrous - unii:81485y3a9a) -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

allergan -

Egypt - English - EDA (Egyptian Drug Authority)

allergan scientific office - ophthalmic solution - 0.3 %

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - gatifloxacin - ophthalmic solution - 0.3

Philippines - English - FDA (Food And Drug Administration)

zuellig pharma corporation - zymar - ophthalmic solution - 3mg/ml (0.3% w/v)